Page last updated: 2024-11-02

pentobarbital and Hyperaldosteronism

pentobarbital has been researched along with Hyperaldosteronism in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miura, Y1
Oyama, T1
Shibata, S1
Sato, K1
Goto, Y1

Other Studies

2 other studies available for pentobarbital and Hyperaldosteronism

ArticleYear
Improved method for measurement of renin activity in human plasma.
    The Tohoku journal of experimental medicine, 1969, Volume: 98, Issue:2

    Topics: Angiotensin II; Animals; Biological Assay; Blood Pressure; Chromatography; Edetic Acid; Female; Huma

1969
[Anesthesia for primary aldosteronism].
    Shujutsu. Operation, 1968, Volume: 22, Issue:6

    Topics: Adrenalectomy; Adult; Anesthesia, Endotracheal; Ethyl Ethers; Female; Halothane; Humans; Hydrocortis

1968